Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBT Margin (2016 - 2025)

Bio Key International (BKYI) has disclosed EBT Margin for 16 consecutive years, with 62.26% as the latest value for Q3 2025.

  • Quarterly EBT Margin fell 2781.0% to 62.26% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 67.71% through Sep 2025, up 862.0% year-over-year, with the annual reading at 62.39% for FY2024, 4922.0% up from the prior year.
  • EBT Margin hit 62.26% in Q3 2025 for Bio Key International, up from 68.8% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 23.39% in Q1 2024 to a low of 387.25% in Q4 2022.
  • Historically, EBT Margin has averaged 109.4% across 5 years, with a median of 88.28% in 2022.
  • Biggest five-year swings in EBT Margin: surged 64419bps in 2021 and later crashed -17343bps in 2022.
  • Year by year, EBT Margin stood at 213.81% in 2021, then plummeted by -81bps to 387.25% in 2022, then soared by 63bps to 145.18% in 2023, then surged by 34bps to 96.25% in 2024, then surged by 35bps to 62.26% in 2025.
  • Business Quant data shows EBT Margin for BKYI at 62.26% in Q3 2025, 68.8% in Q2 2025, and 45.83% in Q1 2025.